Literature DB >> 11295280

Chromosomal rearrangements in thyroid carcinomas: a recombination or death dilemma.

M A Pierotti1.   

Abstract

Well differentiated thyroid carcinomas provide a unique model of human, epithelial cell carcinogenesis. Their molecular characterization has allowed to associate specific genetic alterations to the two papillary and follicular histotypes which, despite their common origin, display different biological and clinical behaviors. A common mechanism of oncogenic activation has been observed in these tumors, based on the peculiar characteristic of thyroid epithelium to generate fusion transforming genes by chromosomal rearrangements. The reasons for this peculiar uniqueness of thyrocytes are not known, but a structural explanation, based on the spatial contiguity in the interphase nuclei of thyrocytes of the two fused genes and enzymatic features of these cells which render them apoptosis resistant to DNA damage, have been proposed to account for this behavior.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11295280     DOI: 10.1016/s0304-3835(01)00439-6

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  8 in total

1.  The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells.

Authors:  Rosa Marina Melillo; Maria Domenica Castellone; Valentina Guarino; Valentina De Falco; Anna Maria Cirafici; Giuliana Salvatore; Fiorina Caiazzo; Fulvio Basolo; Riccardo Giannini; Mogens Kruhoffer; Torben Orntoft; Alfredo Fusco; Massimo Santoro
Journal:  J Clin Invest       Date:  2005-03-10       Impact factor: 14.808

Review 2.  Alterations of the BRAF gene in thyroid tumors.

Authors:  Raffaele Ciampi; Yuri E Nikiforov
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

Review 3.  Cytogenomics of cancers: from chromosome to sequence.

Authors:  Alain Bernheim
Journal:  Mol Oncol       Date:  2010-06-11       Impact factor: 6.603

Review 4.  Molecular pathobiology of thyroid neoplasms.

Authors:  Giovanni Tallini
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

5.  A new mechanism of BRAF activation in human thyroid papillary carcinomas.

Authors:  Alfredo Fusco; Giuseppe Viglietto; Massimo Santoro
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

Review 6.  Potential utility and limitations of thyroid cancer cell lines as models for studying thyroid cancer.

Authors:  Tania Pilli; Kanteti V Prasad; Shankar Jayarama; Furio Pacini; Bellur S Prabhakar
Journal:  Thyroid       Date:  2009-12       Impact factor: 6.568

7.  Genetic and biological subgroups of low-stage follicular thyroid cancer.

Authors:  Christopher A French; Erik K Alexander; Edmund S Cibas; Vania Nose; Julia Laguette; William Faquin; Jeff Garber; Francis Moore; Jonathan A Fletcher; P Reed Larsen; Todd G Kroll
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

8.  Genomic EWS-FLI1 fusion sequences in Ewing sarcoma resemble breakpoint characteristics of immature lymphoid malignancies.

Authors:  Manfred Berger; Uta Dirksen; Andreas Braeuninger; Gabriele Koehler; Heribert Juergens; Manuela Krumbholz; Markus Metzler
Journal:  PLoS One       Date:  2013-02-18       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.